FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CRKL |
CRKL: Crk-like protein |
268.000 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
268.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
268.000 |
Evidence |
|
GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
268.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
268.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
268.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
268.000 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
268.000 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
268.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
268.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
268.000 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
268.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
268.000 |
Evidence |
O
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
268.000 |
Evidence |
O
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
STAT3 |
|
268.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
268.000 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
C6 |
C6: Complement component C6 precursor |
266.000 |
Evidence |
|
SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
265.000 |
Evidence |
|
HPR |
HPR: Haptoglobin-related protein precursor |
SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
265.000 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
263.000 |
Evidence |
|
PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
PSMD6 |
PSMD6, KIAA0107, PFAAP4: 26S proteasome non-ATPase regulatory subunit 6 |
262.000 |
Evidence |
O
|
VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
EPIM |
STX2, EPIM, STX2A, STX2B, STX2C: Syntaxin-2 |
262.000 |
Evidence |
|
EFNA2 |
EFNA2, EPLG6, LERK6: Ephrin-A2 precursor |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
261.000 |
Evidence |
|
VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
STX11 |
STX11: Syntaxin-11 |
261.000 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
259.000 |
Evidence |
|